Modelling the impact of JNJ-1802, a first-in-class dengue inhibitor blocking the NS3-NS4B interaction, on in-vitro DENV-2 dynamics.
Dengue virus (DENV) is a public health challenge across the tropics and subtropics. Currently, there is no licensed prophylactic or antiviral treatment for dengue. The novel DENV inhibitor JNJ-1802 can significantly reduce viral load in mice and non-human primates. Here, using a mechanistic viral ki...
Saved in:
| Main Authors: | Clare P McCormack, Olivia Goethals, Nele Goeyvaerts, Xavier D Woot de Trixhe, Peggy Geluykens, Doortje Borrenberghs, Neil M Ferguson, Oliver Ackaert, Ilaria Dorigatti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-12-01
|
| Series: | PLoS Computational Biology |
| Online Access: | https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1011662&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genomic hotspots in the DENV-2 serotype (E, NS4B, and NS5 genes) are associated with dengue disease severity in the endemic region of India.
by: Varsha Ravi, et al.
Published: (2025-04-01) -
Molecular Docking of Bioactive Components of Tawa-Tawa (Euphorbia hirta l.) Leaves as Inhibitor Against the NS2B-NS3 Protease of DENV-2
by: Conrado P Monterola Jr, et al.
Published: (2024-11-01) -
Inhibitory Effects of Mangifera indica Secondary Metabolites and Their Synthetic Derivatives against SARS-CoV‑2 Mpro and NS2B/NS3 (ZIKV and DENV-2)
by: Gabriella B. Souza, et al.
Published: (2024-10-01) -
i-DENV: development of QSAR based regression models for predicting inhibitors targeting non-structural (NS) proteins of dengue virus
by: Sakshi Gautam, et al.
Published: (2025-06-01) -
A low pre-existing anti-NS1 humoral immunity to DENV is associated with microcephaly development after gestational ZIKV exposure.
by: Sebastián Castro-Trujillo, et al.
Published: (2025-01-01)